It is a pharma private limited company based in Bhubaneswar, Orissa, India, established in 2019.
2019 | Bhubaneswar, Orissa, India | ActiveElipis Pharmaceuticals Private Limited, a active private limited company, was established on 25 October 2019 in Bhubaneswar, Orissa, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24299OR2019PTC031933. Registered under ROC Roc Cuttack. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.20 M.
Its leadership includes Sanghamitra Pradhan (Director), Sikha Suman (Director), Pradeep Kumar Pal (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at House No-10, Plot No-645,12Th Mile Stone Jhandagiri, Kalinga Nagar, Bhubaneswar, Orissa, 751019.
U24299OR2019PTC031933
031933
25 October 2019
₹1.50 M
₹0.20 M
Roc Cuttack
Unlisted
Active
Explore comprehensive insights into Elipis Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanghamitra Pradhan | Director | 25 Oct 2019 | Current |
| Sikha Suman | Director | 25 Oct 2019 | Current |
| Pradeep Kumar Pal | Director | 25 Oct 2019 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Elipis Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 41.35% increase. The company also saw a substantial fall in profitability, with a 134.24% decrease in profit. The company's net worth dipped by a decrease of 1.18%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Elipis Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Elipis Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Elipis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elipis Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Elipis Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Elipis Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Cuttack. was completed.
Sanghamitra Pradhan was appointed as a Director was appointed as a Director on 25 Oct 2019 & has been associated with this company since 6 years 2 months . was recorded as a recent event.
Progress on Sikha Suman was appointed as a Director was appointed as a Director on 25 Oct 2019 & has been associated with this company since 6 years 2 months . was documented.
Pradeep Kumar Pal was appointed as a Director was appointed as a Director on 25 Oct 2019 & has been associated with this company since 6 years 2 months . was recorded as a recent event.
Progress on Elipis Pharmaceuticals Private Limited was registered on 25 Oct 2019 with Roc Cuttack & aged 6 years 2 months as per MCA records. was documented.
The CIN of Elipis Pharmaceuticals Private Limited is U24299OR2019PTC031933.
Elipis Pharmaceuticals Private Limited is headquartered at House No-10, Plot No-645,12Th Mile Stone Jhandagiri, Kalinga Nagar, Bhubaneswar, Orissa, 751019.
Elipis Pharmaceuticals Private Limited was incorporated on 25 October 2019.
The current directors of Elipis Pharmaceuticals Private Limited are
The primary industry of Elipis Pharmaceuticals Private Limited is Trade.
Elipis Pharmaceuticals Private Limited is unlisted.
The authorized capital of Elipis Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹0.20 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX